| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $247.5M | -10.5% |
| Cost of Revenue | $133.3M | -11.1% |
| Gross Profit | $114.2M | -9.9% |
| R&D Expense | $5.5M | +2.3% |
| SG&A Expense | $41.2M | +0.2% |
| Operating Income | -$56.5M | -340.6% |
| Pre-tax Income | -$55.5M | -328.6% |
| Income Tax | $9.3M | +58.7% |
| Net Income | -$64.9M |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.5M | -67.9% |
| Accounts Receivable | $28.9M | -31.7% |
| Inventory | $121.7M | +63.8% |
| Current Assets | $179.8M | -0.0% |
| Total Assets | $277.8M | -18.6% |
| Current Liabilities | $27.0M | -25.7% |
| Total Liabilities | $74.8M | +21.9% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | -153.9% |
| Capital Expenditures | $3.4M | -6.2% |
| Investing Cash Flow | -$33.6M | -703.3% |
| Financing Cash Flow | $10.3M | -67.4% |
| Free Cash Flow | -$21.4M | -171.9% |
| -452.5% |
| EPS (Basic) | -$4.66 | -455.7% |
| EPS (Diluted) | -$4.66 | -461.2% |
| Stockholders' Equity |
| $203.0M |
| -27.5% |